Pharmaceutical Analytical Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

This Pharmaceutical Analytical Testing market segmented By Service Type (Bioanalytical Testing, Method Development & Validation, Stability Testing, Drug Substances Testing, Others), and Geography.

Market Snapshot

Market Snapshot
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The pharmaceutical analytical testing market is expected to register a CAGR of 6.5% over the forecast period. The key contributors in the market growth are focus on analytical testing of biologics and increasing number of clinical trials. According to the International Journal of Environmental Research and Public Health’s published study, around 40 medications are recalled per year in the United States and South Korea. This emerges the need for testing the products and ensure safety. Medicines are intended for better outcome in humans and animals. However, poor quality of medicines would not only affect adevrsely on the health of the patients but also on the fund systems. Therefore, to ensure safety and efficacy of the drugs analytical testing holds an important role.

Scope of the Report

Analytical testing refers to the analysis and evaluation of the drugs from the early stage of discovery till the commercialization of it. Pharmaceutical Analytical Testing Market is segmented By Service Type and Geography.

By Service Type
Bioanalytical Testing
Method Development & Validation
Stability Testing
Drug Substances Testing
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Stability Testing Segment is Expected to Exhibit a Significant Market Growth Over the Forecast Period

Statbility testing is done to evaluate the capability of the drug to retain it’s properties throughout it’s shelf-life. The stability testing is done on the basis of five parameters : Chemical, physical, microbiological, therapeutic and toxicity. The degredation with respect to any of these parameters can lead to health hazards. According to the study published by Journal of Industrial Microbiology & Biotechnology, almost 300 biopharmaceuticals have been patented in the last three decaded. Furthermore, according to the World Health Organization, in 2019, the number of registered trials were around 92% in South East Asia and around 66% in the Eastern Mediterranean region. Hence, these factors are expected to impact positively on the market growth in this segment.

PAT Market Trend.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Pharmaceutical Analytical Testing market owing to increasing number of R&D activities and investments on it. According to the clinical trials.gov, in 2019, around 293,321 studies were registered during the start of the year and around 32,523 at the end of year. Furthermore, in 2019, approximately 48 novel drugs were approved as per the data of the FDA's Center for Drug Evaluation and Research (CDER). According to the Pharmaceutical Research & Manufacturers of America, in 2018, the R&D expenditure by biopharmaceutical companies were around 79.6 billion USD in the United States. Thus, the increasing number of clinical trials and number of approved drugs is expected to boost up the demand of pharmaceutical analytical testing market growth in the North America Region.

Pharmaceutical Analytical Testing Market - Growth Rate by Region

Competitive Landscape

The Pharmaceutical Analytical Testing market consists of several interational as well as local companies. Some of the well-known companies in this market include Laboratory Testing Inc., Eurofins Scientific, SGS SA, Toxikon Inc., Pace Analytical Services, Intertek Pharmaceutical Services, Boston Analytical, West Pharmaceutical Services Inc. and Steris

Recent Developments

In September 2020: Almac Sciences launched GMP lot release and stability testing services to support drug substance and drug product programs for novel biosimilars and biologics. 

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Number of Clinical Trials

      2. 4.2.2 Focus on Analytical Testing of Biologics & Biosimilars

      3. 4.2.3 Increased Trend of Outsourcing Laboratory Testing Services

    3. 4.3 Market Restraints

      1. 4.3.1 Complex Regulatory Framework for Maintaining Laboratories

      2. 4.3.2 Challenges in the Development of Proper Analytical Techniques

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Service Type

      1. 5.1.1 Bioanalytical Testing

      2. 5.1.2 Method Development & Validation

      3. 5.1.3 Stability Testing

      4. 5.1.4 Drug Substances Testing

      5. 5.1.5 Others

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Laboratory Testing Inc.

      2. 6.1.2 Eurofins Scientific

      3. 6.1.3 SGS SA

      4. 6.1.4 Toxikon Inc.

      5. 6.1.5 Pace Analytical Services

      6. 6.1.6 Intertek Phamaceutical Services

      7. 6.1.7 Boston Analytical

      8. 6.1.8 West Pharmaceutical Services Inc.

      9. 6.1.9 Steris

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Pharmaceutical Analytical Testing Market market is studied from 2018 - 2026.

The Pharmaceutical Analytical Testing Market is growing at a CAGR of 6.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Steris, Intertek Pharmaceutical Services, Pace Analytical Services, SGS SA, Boston Analytical are the major companies operating in Pharmaceutical Analytical Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!